Mon. May 25th, 2026
Spread the love
views

0

7 total views, 7 views today

Apple has fallen victim to the Asian contagion, according to CEO
Tim Cook as sales in China plummeted.

An Apple store in China.

 

Shares of the iPhone maker cratered nearly 8 percent in extended
trading Wednesday — knocking some $50 billion off the market cap
after the company took the unusual step of cutting its revenue
guidance.

In a letter to investors, Cook said that Apple expects to report
$84 billion in revenue during its next earnings report — it
previously forecasted $91 billion.

Cook placed the blame on “both macroeconomic and Apple-specific
factors,” and said that the iPhone maker failed to “foresee the
magnitude of the economic deceleration” in emerging markets. The
CEO never cited the $1,500 price point for the most expensive
model.

Indeed, Cook said that “over 100 percent” of Apple’s worldwide
revenue decline “occurred in Greater China across iPhone, Mac and
iPad.”

Cook also said that Apple hurt its bottom line when it slashed
the price of iPhone battery replacements early last year after it
was caught red-handed slowing down older iPhones to preserve their
aging batteries.

Consumers, he said, are taking advantage of the “significantly
reduced pricing” to extend the lives of their current phones and
avoid an upgrade.

“While Greater China and other emerging markets accounted for
the vast majority of the year-over-year iPhone revenue decline, in
some developed markets, iPhone upgrades also were not as strong as
we thought they would be,” Cook said.

Though Cook did not acknowledge the eye-watering prices of
Apple’s new iPhone XS and XS Max — which start at $999 and top out
at $1,449 — as a contributing factor to Apple’s woes, he did point
a finger at “US dollar strength-related price increases.”

He added that the ongoing extinction of carrier subsidies —
which reduced the sticker shock of expensive handsets — contributed
to the poor performance.

Sales of Apple’s cheaper iPhone XR have also been a thorn in
Apple’s side since it hit stores in late October. The Cupertino,
Calif.-based company has seen its stock drop more than 30 percent
as numerous parts and chip suppliers for the iPhone have slashed
sales forecasts.

The tech giant has gone as far as assigning members of its
marketing team to work full-time on boosting sales, and has upped
the amount it is willing to pay for devices traded in toward the
purchase of a new iPhone, according to a report earlier this
month.

As recently as last week, Apple was blasting out emails to
shoppers that advertised the XR at $449[1] — provided
customers trade in an older device.

Shares of Apple were down 7.4 percent in extended trading, at
$146.

Post Views: 7

References

  1. ^
    advertised the XR at $449
    (nypost.com)

Read more

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.